PE25.11 Mapping HIV prevention product preferences among adolescent girls and young women at high risk of HIV: results from a discrete choice experiment in South AfricaE-posterProduct acceptability and adherence
PE26.01 Surge strategies improve HIV testing efficiency and linkage to treatment among female sex workers in Nairobi, KenyaE-posterTherapeutic vaccines, viral reservoirs and eradication/remission
PE26.02 Effect of a novel HIV-1 RNA testing intervention to detect acute and prevalent HIV infection in young adults and reduce HIV transmission in Kenya: A randomized controlled trialE-posterTherapeutic vaccines, viral reservoirs and eradication/remission
PE27.01 Association between Basal Metabolic Index and vaccine-induced HIV-1 adaptive immunityE-posterTherapeutic vaccines, viral reservoirs and eradication/remission
PE27.02 The influence of HIV-1 subtype C LTR genotype on latency potentialE-posterTherapeutic vaccines, viral reservoirs and eradication/remission
PE27.03 Impact of baseline variables on time to viral rebound after treatment interruption in acutely treated HIV-1 infected participantsE-posterTherapeutic vaccines, viral reservoirs and eradication/remission
PE28.01 An analysis of gender-based violence and HIV risk among adolescents and youth across 10 countriesE-posterTransmission of HIV
PE28.02 Variable HIV seroincidence rates in a cohort of high-risk men who have sex with men (MSM) and transgender women (TGW) in ChinaE-posterTransmission of HIV
PE28.03 Site-level prevalence of gonorrhea and chlamydia is correlated with site-level HIV incidence in African women seeking contraceptionE-posterTransmission of HIV
PE28.04 Circulating South African transmitted/founder HIV-1 subtype C uses CCR5 and not CXCR4 or CCR3 for cell entryE-posterTransmission of HIV
seek-warrow-warrow-eseek-e351 - 360 of 444 items